MDX-1342

BIOLOGICAL2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Chronic Lymphocytic LeukemiaRheumatoid Arthritis

Phase 1

Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)

CompletedNCT00593944

Bristol-Myers SquibbChronic Lymphocytic Leukemia

Start: 2008-08-31End: 2010-05-31Updated: 2013-05-22

Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis

CompletedNCT00639834

Bristol-Myers SquibbRheumatoid Arthritis

Start: 2008-02-29End: 2010-06-30Updated: 2013-05-22